PF-2334

N/A

Report date: 2023/05/11 13:42:05

NME

Base Information

Drug NamePF-2334

Drug Alias NamePF-2334

ClassificationSmall molecules

Mechanisms of ActionDopamine D1 receptor agonists

TargetsDopamine D1 receptor

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A